Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
accordion, agent, bank, Citibank, clarify, create, default, direct, discretion, dispose, event, extinguishment, feature, financing, grant, greatest, guarantee, guaranteed, hedging, indemnification, indirect, installment, lien, loan, merger, month, negotiated, notice, Notwithstanding, NYFRB, open, overnight, penalty, percent, permitted, premium, prime, priority, redeem, Restated, scheduled, simple, subfacility, suspended, thereunder, transfer, Unamortized, wholly, withheld
Removed:
equal, excluding, freight, initiated, located, March, obsolescence, percentage, substance, unit
Filing tables
Filing exhibits
Associated AVNS transcripts
AVNS similar filings
Filing view
External links
Exhibit 32(b)
Certification of Chief Financial Officer
Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code
I, Michael C. Greiner, Chief Financial Officer of Avanos Medical, Inc., certify that, to my knowledge:
(1)the Form 10-Q, filed with the Securities and Exchange Commission on August 9, 2022 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations of Avanos Medical, Inc.
| Date: August 9, 2022 | /s/ Michael C. Greiner | |||||||
| Michael C. Greiner Chief Financial Officer | ||||||||